Our Next Show: The Ins and Outs of Daratumumab for Myeloma Patients with Dr. Torben Plesner @ 9 am Eastern, Wednesday, Sept 28

Dr. Torben Plesner, MD is Professor and Head of the Department of Hematology at the Center Lillebaelt, Vejle Hospital in Denmark. Dr. Plesner is founder of the Clinical Research Unit at the hospital and participates on the council, board, committee and networks for the European Hematology Association and the European Myeloma Network. He has helped evaluate research and early clinical trials for daratumumab since its inception. He is on the council and boards of both the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).
Thanks to our episode sponsor, Takeda Oncology.
Dr. Torben Plesner, MD is Professor and Head of the Department of Hematology at the Center Lillebaelt, Vejle Hospital in Denmark. Dr. Plesner is founder of the Clinical Research Unit at the hospital and participates on the council, board, committee and networks for the European Hematology Association and the European Myeloma Network. He has helped evaluate research and early clinical trials for daratumumab since its inception. He is on the council and boards of both the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).
Thanks to our episode sponsor, Takeda Oncology.


about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can contribute to cures by joining HealthTree Cure Hub and joining clinical research. Founder and CEO of HealthTree Foundation.
More on HealthTree Programs
Trending Articles





Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.